Granules India

Market Cap: Small Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE101D01020
NSEID: GRANULES
BSEID: 532482

INR

579.00

5.5 (0.96%)

BSENSE

Dec 17

BSE+NSE Vol: 18.02 lacs

{
  "main_header": {
    "sid": 580033,
    "name": "Granules India",
    "stock_name": "Granules India",
    "full_name": "Granules India Ltd",
    "name_url": "stocks-analysis/granules-india",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "579.00",
    "chg": 5.5,
    "chgp": "0.96%",
    "dir": 1,
    "prev_price": "573.50",
    "mcapval": "14,018.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 532482,
    "symbol": "GRANULES",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE101D01020",
    "curr_date": "Dec 17",
    "curr_time": "",
    "bse_nse_vol": "18.02 lacs",
    "exc_status": "Active",
    "traded_date": "Dec 17, 2025",
    "traded_date_str": "2025 12 17",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/granules-india-580033-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Granules India Sees Shift in Market Assessment Amid Technical and Financial Developments",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/granules-india-upgraded-to-buy-on-improved-technicals-and-solid-fundamentals-3759441",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GranulesIndia_mojoScore_3759441.png",
        "date": "2025-12-16 08:12:08",
        "description": "Granules India, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable revision in its market evaluation, reflecting changes across technical indicators, valuation metrics, financial trends, and overall quality parameters. This article analyses the factors influencing the recent shift in the company's assessment and what it means for investors navigating the evolving pharmaceutical landscape."
      },
      {
        "title": "Granules India Shows Mixed Technical Signals Amid Price Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/granules-india-technical-momentum-shifts-to-bullish-amid-mixed-market-returns-3754677",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GranulesIndia_technicaldot_3754677.png",
        "date": "2025-12-10 08:06:54",
        "description": "Granules India, a key player in the Pharmaceuticals & Biotechnology sector, has exhibited a notable shift in its price momentum and technical indicators, reflecting a nuanced market assessment. The stock’s recent trading activity and technical parameters suggest a complex interplay of bullish and mildly bearish signals, warranting close attention from investors and market analysts alike."
      },
      {
        "title": "Granules India’s Market Assessment Reflects Mixed Signals Amidst Flat Financials and Technical Shifts",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/granules-india-downgraded-to-hold-amid-mixed-financial-and-technical-signals-3752869",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GranulesIndia_mojoScore_3752869.png",
        "date": "2025-12-09 08:17:05",
        "description": "Granules India, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation following a combination of flat quarterly financial results and nuanced technical indicators. This shift reflects a complex interplay of quality, valuation, financial trends, and technical factors that investors should carefully consider."
      },
      {
        "title": "Granules India Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/granules-india-technical-momentum-shifts-amid-mixed-market-signals-3752764",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GranulesIndia_technicaldot_3752764.png",
        "date": "2025-12-09 08:10:47",
        "description": "Granules India, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of market forces and indicator signals. Recent data reveals a transition from a bullish to a mildly bullish trend, accompanied by mixed signals from key technical indicators such as MACD, RSI, and moving averages, suggesting a nuanced outlook for investors."
      },
      {
        "title": "Granules India Sees Shift in Market Assessment Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/granules-india-upgraded-to-buy-on-strong-technicals-and-solid-financial-metrics-3740515",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GranulesIndia_mojoScore_3740515.png",
        "date": "2025-12-02 08:14:14",
        "description": "Granules India, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable revision in its market evaluation, reflecting a complex interplay of technical indicators, valuation metrics, financial trends, and quality parameters. This article analyses the factors influencing the recent shift in the company’s assessment and what it means for investors navigating the current market landscape."
      },
      {
        "title": "Granules India Technical Momentum Shifts Signal Market Interest",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/granules-india-technical-momentum-shifts-to-bullish-amid-mixed-market-returns-3740108",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GranulesIndia_technicaldot_3740108.png",
        "date": "2025-12-02 08:06:41",
        "description": "Granules India has exhibited a notable shift in its technical momentum, reflecting evolving market dynamics within the Pharmaceuticals & Biotechnology sector. Recent price movements and technical indicators suggest a transition towards a more bullish stance, highlighting investor attention amid broader market trends."
      },
      {
        "title": "How has been the historical performance of Granules India?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-granules-india-3739187",
        "imagepath": "",
        "date": "2025-12-01 23:03:41",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Revenue and Profitability Trends</strong></p>\n<p>Granules India's net sales have shown a robust upward trend over the past six years, rising from ₹2,279.20 crores in March 2019 to ₹4,481.61 crores in March 2025. The company experienced significant growth between 2019 and 2021, with sales increasing by over 40% in two years, reflecting strong market demand and operational expansion. However, sales plateaued around ₹4,500 crores in the subsequent years, indicating a stabilisation phase.</p>\n<p>Operating profit margins, excluding other income, have fluctuated notably. The margin peaked at 26.42% in March 2021 but moderated to 21.21% by March 2025. This variation suggests periods of cost pressure or strategic investments impacting profitability. Despite this, the operating profit (PBDIT) rose fr..."
      },
      {
        "title": "Why is Granules India falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-granules-india-fallingrising-3726635",
        "imagepath": "",
        "date": "2025-11-25 00:33:42",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Performance and Market Context</strong></p>\n<p>Granules India’s share price has been on a downward trajectory over the past week, falling by 5.34%, significantly underperforming the Sensex, which remained almost flat with a marginal decline of 0.06% during the same period. The one-month trend mirrors this weakness, with the stock down 5.32% while the Sensex gained 0.82%. Year-to-date, the stock has declined by 10.20%, contrasting sharply with the Sensex’s robust 8.65% gain. Even over the last year, Granules India’s shares have fallen by 4.81%, whereas the benchmark index rose by 7.31%. These figures highlight a persistent underperformance relative to the broader market.</p>\n<p>Despite this short-term weakness, the stock has delivered strong returns over a longer horizon, with a ..."
      },
      {
        "title": "Granules India Evaluation Revised Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/granules-india-downgraded-to-hold-by-marketsmojo-amid-mixed-technical-and-financial-signals-3717210",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/GranulesIndia_mojoScore_3717210.png",
        "date": "2025-11-20 08:05:09",
        "description": "Granules India, a key player in the Pharmaceuticals & Biotechnology sector, has undergone a revision in its market assessment following a detailed analysis of its quality, valuation, financial trends, and technical indicators. This reassessment reflects a nuanced view of the company’s current position amid fluctuating market conditions and sectoral dynamics."
      }
    ],
    "total": 421,
    "sid": "580033",
    "stock_news_url": "https://www.marketsmojo.com/news/granules-india-580033"
  },
  "announcements": [
    {
      "caption": "Updates",
      "datetime": "12-Dec-2025",
      "details": "Updates",
      "source": "BSE"
    },
    {
      "caption": "Updates",
      "datetime": "12-Dec-2025",
      "details": "Updates",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "04-Dec-2025",
      "details": "Press Release",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Granules India Ltd has declared <strong>150%</strong> dividend, ex-date: 31 Jul 25",
          "dt": "2025-07-31",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Granules India Ltd has announced <strong>1:10</strong> stock split, ex-date: 23 Mar 15",
          "dt": "2015-03-23",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Granules India Sees Shift in Market Assessment Amid Technical and Financial Developments

2025-12-16 08:12:08

Granules India, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable revision in its market evaluation, reflecting changes across technical indicators, valuation metrics, financial trends, and overall quality parameters. This article analyses the factors influencing the recent shift in the company's assessment and what it means for investors navigating the evolving pharmaceutical landscape.

Granules India Shows Mixed Technical Signals Amid Price Momentum Shift

2025-12-10 08:06:54

Granules India, a key player in the Pharmaceuticals & Biotechnology sector, has exhibited a notable shift in its price momentum and technical indicators, reflecting a nuanced market assessment. The stock’s recent trading activity and technical parameters suggest a complex interplay of bullish and mildly bearish signals, warranting close attention from investors and market analysts alike.

Granules India’s Market Assessment Reflects Mixed Signals Amidst Flat Financials and Technical Shifts

2025-12-09 08:17:05

Granules India, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation following a combination of flat quarterly financial results and nuanced technical indicators. This shift reflects a complex interplay of quality, valuation, financial trends, and technical factors that investors should carefully consider.

Granules India Technical Momentum Shifts Amid Mixed Market Signals

2025-12-09 08:10:47

Granules India, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of market forces and indicator signals. Recent data reveals a transition from a bullish to a mildly bullish trend, accompanied by mixed signals from key technical indicators such as MACD, RSI, and moving averages, suggesting a nuanced outlook for investors.

Granules India Sees Shift in Market Assessment Amid Mixed Financial and Technical Signals

2025-12-02 08:14:14

Granules India, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable revision in its market evaluation, reflecting a complex interplay of technical indicators, valuation metrics, financial trends, and quality parameters. This article analyses the factors influencing the recent shift in the company’s assessment and what it means for investors navigating the current market landscape.

Granules India Technical Momentum Shifts Signal Market Interest

2025-12-02 08:06:41

Granules India has exhibited a notable shift in its technical momentum, reflecting evolving market dynamics within the Pharmaceuticals & Biotechnology sector. Recent price movements and technical indicators suggest a transition towards a more bullish stance, highlighting investor attention amid broader market trends.

How has been the historical performance of Granules India?

2025-12-01 23:03:41

Revenue and Profitability Trends

Granules India's net sales have shown a robust upward trend over the past six years, rising from ₹2,279.20 crores in March 2019 to ₹4,481.61 crores in March 2025. The company experienced significant growth between 2019 and 2021, with sales increasing by over 40% in two years, reflecting strong market demand and operational expansion. However, sales plateaued around ₹4,500 crores in the subsequent years, indicating a stabilisation phase.

Operating profit margins, excluding other income, have fluctuated notably. The margin peaked at 26.42% in March 2021 but moderated to 21.21% by March 2025. This variation suggests periods of cost pressure or strategic investments impacting profitability. Despite this, the operating profit (PBDIT) rose fr...

Why is Granules India falling/rising?

2025-11-25 00:33:42

Recent Price Performance and Market Context

Granules India’s share price has been on a downward trajectory over the past week, falling by 5.34%, significantly underperforming the Sensex, which remained almost flat with a marginal decline of 0.06% during the same period. The one-month trend mirrors this weakness, with the stock down 5.32% while the Sensex gained 0.82%. Year-to-date, the stock has declined by 10.20%, contrasting sharply with the Sensex’s robust 8.65% gain. Even over the last year, Granules India’s shares have fallen by 4.81%, whereas the benchmark index rose by 7.31%. These figures highlight a persistent underperformance relative to the broader market.

Despite this short-term weakness, the stock has delivered strong returns over a longer horizon, with a ...

Granules India Evaluation Revised Amid Mixed Financial and Technical Signals

2025-11-20 08:05:09

Granules India, a key player in the Pharmaceuticals & Biotechnology sector, has undergone a revision in its market assessment following a detailed analysis of its quality, valuation, financial trends, and technical indicators. This reassessment reflects a nuanced view of the company’s current position amid fluctuating market conditions and sectoral dynamics.